Presentation is loading. Please wait.

Presentation is loading. Please wait.

A B C D G G/A Figure 1. Sequencing reveals mosaicism for point mutation. A. Sequencing shows a homozygous c.862 G>A mutation in the DNA from tumor of unilaterally.

Similar presentations


Presentation on theme: "A B C D G G/A Figure 1. Sequencing reveals mosaicism for point mutation. A. Sequencing shows a homozygous c.862 G>A mutation in the DNA from tumor of unilaterally."— Presentation transcript:

1 A B C D G G/A Figure 1. Sequencing reveals mosaicism for point mutation. A. Sequencing shows a homozygous c.862 G>A mutation in the DNA from tumor of unilaterally affected proband (Family 1). B. the mutation was found in 15-20% of the proband’s leukocyte DNA as a small A peak present in the same position as the wild type G peak (green arrow). C, D. No mutation was observed in the DNA isolated from the mother or father’s blood.

2 C A Normal blood Bilateral blood Bilateral blood T G A C Normal blood A T C G B D Normal blood Bilateral tumor Heterozygous 2 bp  T G R C V M A K W A T C G Figure 2. QM-PCR detected mosiac deletions in blood of bilaterally affected probands: A. QM PCR reproducibly showed a subtle shoulder on the exon 23 peak (arrow) in the blood of bilaterally affected proband (Family 2), compared to exon 23 peak of a normal control and other normal exons 19 and 24 in both the normal control blood and bilaterally affected blood. B. Sequence showed a heterozygous 2 base pair deletion in the tumor (c2478delTC) (closed circles, normal sequence; open circles, mutant sequence; deleted bases below mutant; automatic reading detects the heterozygous mutant) and a low level of the same deletion in the blood of the bilaterally affected proband (automatic reading fails to detect the mosaic deletion). C. QM PCR showed a small peak preceding exon 10 peak in the blood from a bilaterally affected proband (Family 3), compared to normal exon 10 peak from a control blood and other normal peaks from both the proband and the normal control. B. Sequence showed a small population of DNA with 2 base pairs deleted (deletion site not shown). (??not detected? In an intron??) Bilateral blood Mosaic 2 bp  T G A C Bilateral blood Mosaic 2 bp 

3 Bilateral tumor 0 copies exon 3 2 copies other exons Bilateral blood 1.5 copies exon 3 Normal blood E Figure 2. QM-PCR detected mosiac deletions in blood of bilaterally affected probands: E. QM-PCR showed only background PCR product for exon 3 in retinoblastoma tumor of the proband in family 4, indicating homozygosity for the deletion. In comparison to the 2 copies of exon 3 in normal blood control, blood of the proband showed 1.5 copies of exon 3, suggesting mosaicism for the exon 3 deletion.

4 A C B Internal control R255X Blood
% mutant DNA 100 10 2 N B S N Neg Internal control R255X Blood Sperm C G A T B Figure 3. Suspicion of mosaicism raised on sequence, confirmed by ASPCR. Unilateral, non-familial retinoblastoma had conventionally a 15% risk of germline RB1 mutation, with 7% risk of transmission to offspring. The half-blackened square represents the unilaterally affected individual. Sequence suggested a mosaic mutation in blood, indicated by the arrow indicating a low level of mutation; no tumor was available to confirm the mutation. ASPCR for the nonsense mutation R255X showed the proportion of mutant DNA in the proband’s blood to be about 5%, or the proportion of mutant leukocytes to be about 10%. Risk of transmission to offspring is reduced to about 5%. B, C. Sequence and ASPCR on sperm DNA showed no detectable signal (less than 1%), in comparison to blood DNA. Risk of transmission to offspring is reduced to less than 1%. N, normal (R255wt) control DNA; Neg, negative control (water); % mutant DNA included 100% (homozygous R255X tumor control), 10% and 2% mixtures of homozygous tumor to wild type DNA; B, proband blood DNA; S, proband sperm DNA. Mellone’s comments: Proband is not a true mosaic? (mosaic only in somatic cells or is he really a true germline (mosaic in all areas of body) mosaic such that mosaicism occurs in ,1% of germ cells; since level of detection is , 2%) BG: yes true mosaic, who said had to affect every tissue? ONLY SAY: NO EVIDENCE OF MUTATION IN SPERM; THEREFORE RISK OF TRANSMISSION TO OFFSPRING LESS THAT 1%. Still don’t understand why add normal DNA at a fixed concentration, why not amplify something within mutant DNA as an internal control? DON’T KNOW WHAT YOU MEAN Why is it necessary to show that it is at a constant amount, when that amount is actually fixed by you? WHEN THE REACTION IS SET UP TRY TO COVER THE RANGE; THEN THE PATIENT SAMPLE HAS A VALID COMPARATOR TO EXTIMATE THE % MOSAICISM. What is the purpose in showing that normal DNA is constant in each but that only the amount of mutant DNA is different (dilutions)? Is the purpose of the internal control strictly to show that DNA is present in a consistent amount in each lane? YES (2 reasons: 1. to make sure that DNA is present and it amplifies under their conditions and 2. to mimic the in vivo model)

5 A B C ??? C A T G C Y I-1 I-2 II-1 II-2 II-3 Blood I-2 Blood II-1
Amniocytes fetus II-2 Cord blood newborn II-2 Amniocytes fetus II-3 Figure 4. Suspicious by sequencing and confirmed by ASPCR A. Pedigree of family with unilaterally affected mother (I-2) and two children (II-2, II-3) at risk for familial retinoblastoma. Black and half-black circles represent bilaterally and unilaterally affected individuals respectively; black dot indicates presence of the constitutional mutation. B. Sequence showed the heterozygous RB1 mutant allele (R445X) in the bilaterally affected daughter’s blood (II-1), but not in the blood of the mother (I-2) or her second child (II-2). Her third child (II-3) was shown prenatally to carry the same mutation the affected child (II-1). C. ASPCR analysis for the nonsense mutation R455X on blood samples of unilaterally affected mother (I-2) and her bilaterally affected daughter (II-1). Normal (R455wt) control DNA sample, labeled N, Neg, negative control????. The proportion of mutant leukocytes in the mother’s blood was approximately 20%. N 1/10 1/100 1/20 Neg II-1 1/1 I-2 R455X R455wt ??? C

6 Table 1: Frequency of Mosaicism
All mosaic cases to be included.

7 Total Tested 320 Mutation Found 294 92% No Mutation Found 26 8% AS-PCR
Extrapolation from AS-PCR-detected mosaicsm indicates that the majority of “missing” RB1 mutations are mosaic. (Other mutation detection technologies do not detect mosaicism.) Total Tested 320 Mutation Found % No Mutation Found 26 8% AS-PCR % non AS-PCR % Mosaic % Not Mosaic % % % Table 2: All Mosaic cases Update this table Extrapolated Figure 4


Download ppt "A B C D G G/A Figure 1. Sequencing reveals mosaicism for point mutation. A. Sequencing shows a homozygous c.862 G>A mutation in the DNA from tumor of unilaterally."

Similar presentations


Ads by Google